CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,178,623 | -17.9% | 136,123 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $7,526,241 | +21.2% | 134,062 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $6,209,310 | +22.1% | 137,283 | +9.8% | 0.00% | +100.0% |
| Q4 2022 | $5,083,851 | -38.3% | 125,064 | -0.9% | 0.00% | -66.7% |
| Q3 2022 | $8,244,000 | +6.4% | 126,147 | -1.0% | 0.00% | +50.0% |
| Q2 2022 | $7,745,000 | +4.5% | 127,458 | +7.9% | 0.00% | 0.0% |
| Q1 2022 | $7,415,000 | +6.7% | 118,123 | +28.8% | 0.00% | 0.0% |
| Q4 2021 | $6,948,000 | -35.6% | 91,695 | -4.9% | 0.00% | -33.3% |
| Q3 2021 | $10,796,000 | -48.0% | 96,452 | -24.8% | 0.00% | -40.0% |
| Q2 2021 | $20,756,000 | +44.6% | 128,220 | +8.9% | 0.01% | +25.0% |
| Q1 2021 | $14,351,000 | -69.3% | 117,782 | -61.4% | 0.00% | -71.4% |
| Q4 2020 | $46,752,000 | +293.8% | 305,346 | +115.1% | 0.01% | +250.0% |
| Q3 2020 | $11,872,000 | -12.4% | 141,934 | -23.1% | 0.00% | -20.0% |
| Q2 2020 | $13,560,000 | +68.0% | 184,512 | -3.0% | 0.01% | +66.7% |
| Q1 2020 | $8,071,000 | -0.6% | 190,307 | +42.7% | 0.00% | 0.0% |
| Q4 2019 | $8,123,000 | +570.2% | 133,379 | +351.3% | 0.00% | – |
| Q3 2019 | $1,212,000 | -72.5% | 29,557 | -60.6% | 0.00% | -100.0% |
| Q2 2018 | $4,411,000 | – | 75,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |